Composition: Anastrozole 1mg
Indication: Anastrozole is an aromatase inhibitor used to treat breast cancer in women who have gone through menopause.
Composition: Bendamustine Hydrochloride 2.5mg/ml
Indication: Bendamustine hydrochloride is used as monotherapy or in combination with other medicines for the treatment of the following forms of cancer:
chronic lymphocytic leukemia in cases where fludarabine combination chemotherapy is not appropriate, non-Hodgkin lymphomas, which had not, or only shortly, responded to prior rituximab treatment, multiple myeloma in cases where thalidomide or bortezomib containing therapy is not appropriate.
Composition: Bicalutamide 50mg
Indication: Bicalutamide is an anti-androgen used to treat prostrate cancer. It works by blocking the effects of male hormones such as testosterone.
Composition: Bortezomib 3.5mg
Indication:
Bortezomib Accord is proteasome inhibitor used for the treatment of multiple myeloma in patients older than 18 years:
- alone or together with the medicines PEGylated liposomal doxorubicin or dexamethasone, for patients whose disease is worsening (progressive) after receiving at least one prior treatment and for whom blood stem cell transplantation was not successful or is unsuitable
- in combination with the medicines melphalan and prednisone, for patients whose disease has not been previously treated and are unsuitable for high-dose chemotherapy with blood stem cell transplantation
- in combination with the medicines dexamethasone or dexamethasone together with thalidomide, for patients whose disease has not been previously treated and before receiving high-dose chemotherapy with blood stem cell transplantation (induction treatment).
Bortezomib Accord is used for the treatment of mantle cell lymphoma in patients 18 years or older in combination with the medicines rituximab, cyclophosphamide, doxorubicin and prednisone, for patients whose disease has not been previously treated and for whom blood stem cell transplantation is unsuitable.
Composition: Capecitabine 500mg
Indication: Capecitabine Accord is used in the treatment of colon, rectal, gastric, or breast cancers. It is used to prevent new occurrence of colon cancer after complete removal of the tumor by surgery. Capecitabine Accord may be used either alone or in combination with other medicines.
Composition: Dacarbazine 200mg
Indication: Dacarbazine Lipomed is a chemotherapeutic drug currently used to treat different forms of cancer.
Composition: Docetaxel 20mg/1ml
Indication: Docetaxel is a chemotherapeutic antimitotic agent that works by interfering with cell division. It is used in the treatment of various types of cancer such as breast, ovarian or prostate.
Composition: Docetaxel 80mg/4ml
Indication: Docetaxel is a chemotherapeutic antimitotic agent that works by interfering with cell division. It is used in the treatment of various types of cancer such as breast, ovarian or prostate.
Composition: Docetaxel 20mg/0.5ml
Indication: Docetaxel is a chemotherapeutic antimitotic agent that works by interfering with cell division. It is used in the treatment of various types of cancer such as breast, ovarian or prostate.
Composition: Docetaxel 80mg/2ml
Indication: Docetaxel is a chemotherapeutic antimitotic agent that works by interfering with cell division. It is used in the treatment of various types of cancer such as breast, ovarian or prostate.
Composition: Doxorubicin hydrochloride 50mg/25ml
Indication: Doxorubicin is used to treat different forms of cancer. Doxorubicin belongs to the family of anthracycline antibiotics and exerts its effect by killing the cell. The mechanism of action probably reflects a complex system of multiple mechanisms related to the formation of free radicals, its action on DNA, or on the cell membrane.
Composition: Exemestane 25mg
Indication: Exemestane is used to treat hormone dependent early breast cancer in postmenopausal women after they have completed 2-3 years of treatment with the medicine tamoxifen. Exemestane is also used to treat hormone dependent advanced breast cancer in postmenopausal women when a different hormonal drug treatment has not worked well enough.
Composition: Granisetron 1 mg/ml
Indication: This belongs to a group of medicines called “5-HT3 receptor antagonists” or “anti-emetics”. Grani-Denk 1 mg/ml is used to prevent or treat nausea and vomiting (feeling and being sick) caused by other medical treatments, such as chemotherapy or radiotherapy for cancer, and by surgery. The solution for injection or infusion is for use in adults and children from 2 years of age.
Composition: Gemcitabine 200mg
Indication: Antineoplastic. Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer and for the treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Also in cases of breast cancer, non-small cell lung cancer, and ovarian cancer.
Composition: Imatinib 100mg
Indication: Antineoplastic, protein tyrosine kinase inhibitor.
Imatinib is indicated for newly diagnosed chronic Myeloid Leukemia (CML) patients and in Acute Lymphoblastic Leukemia (ALL).
